SEC Form 4 · accession 0001209191-16-126265

Clearside Biomedical, Inc. · CLSD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Daniel H. White

Officer — President and CEO · Director

Period of report

Jun 7, 2016

Accepted (ET)

Jun 7, 2016 · 4:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001539029

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jun 7, 2016	C	66,518	—	A	530,163	D
Common Stock	Jun 7, 2016	X	657	$0.022	A	530,820	D
Common Stock	Jun 7, 2016	S	3	$7.00	D	530,817	D
Common Stock^F4	holding	—	—		—	40,909	I	By White Family Trust
Common Stock^F5	holding	—	—		—	301	I	As UTMA custodian for son
Common Stock^F5	holding	—	—		—	844	I	As UTMA custodian for son
Common Stock^F5	holding	—	—		—	1,188	I	As UTMA custodian for son

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A Preferred Stock^F2	—	Jun 7, 2016	C	133,234	D	—	—	Common Stock	60,560	D
Series B Preferred Stock^F2	—	Jun 7, 2016	C	13,110	D	—	—	Common Stock	5,958	D
Warrant to Purchase Common Stock (right to buy)^F6	$0.022	Jun 7, 2016	X	657	D	Apr 28, 2014	—	Common Stock	657	D

Explanation of responses

F1Represents shares received upon conversion of shares of Series A Preferred Stock and Series B Preferred Stock.
F2Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.454545 shares of the Issuer's common stock. The Preferred Stock had no expiration date.
F3On June 7, 2016, the reporting person exercised a warrant to purchase 657 shares of Issuer's common stock for $0.022 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 3 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 654 shares.
F4These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F5These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
F6This warrant would have expired upon the closing of the Issuer's initial public offering.